Barclays PLC Ptc Therapeutics, Inc. Call Options Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	BUY	$30.39 - $37.66 $638,190 - $790,859	21,000 New	21,000 $779,000
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $460,676 - $647,636	-16,400 Reduced 78.85%	4,400 $165,000
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $3.45 Million - $4.86 Million	-101,700 Reduced 83.02%	20,800 $978,000
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $3.06 Million - $5.7 Million	119,100 Added 3502.94%	122,500 $4.13 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $2.21 Million - $3.06 Million	-146,300 Reduced 97.73%	3,400 $57,000
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $2.52 Million - $3.24 Million	149,700	149,700 $3 Million

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.